Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20–21 Registry
Viruses · 2024
DOI: 10.3390/v16071028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Juan Pablo Arango-Ibanez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cali 760032, Colombia. Hauptthemen laut MEDLINE: COVID-19, Fatigue, SARS-CoV-2, Myalgia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tecnoquimicas S.A., Centro de Investigaciones Clínicas (CIC).
Abstract (Originalsprache)
Long COVID presents with diverse symptoms after COVID-19. Different clusters of symptoms have been reported; however, their persistence beyond 2 years after COVID-19 remains unclear. In this cohort study, we prospectively evaluated individuals with previous severe COVID-19 presenting with long COVID at a two-year follow-up. We characterized the included patients and performed a cluster analysis of symptoms through multiple correspondence analysis and hierarchical clustering. A total of 199 patients with long COVID were included. The median age was 58 years (48–69), 56% were male, and the median follow-up time since the COVID-19 diagnosis was 26 months (IQR: 25, 27). Three symptom clusters were identified: Cluster 1 is characterized by fatigue, myalgia/arthralgia, a low prevalence of symptoms, and a lack of specific symptoms; Cluster 2 is defined by a high prevalence of fatigue, myalgia/arthralgia, and cardiorespiratory symptoms, including palpitations, shortness of breath, cough, and chest pain; and Cluster 3 is demonstrated a high prevalence of ageusia, anosmia, fatigue, and cardiorespiratory symptoms. Our study reinforces the concept of symptom clustering in long COVID, providing evidence that these clusters may persist beyond two years after a COVID-19 diagnosis. This highlights the chronic and debilitating nature of long COVID and the importance of developing strategies to mitigate symptoms in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cali 760032, Colombia.
- Departamento de Cardiología, Centros de Diagnóstico y Medicina Avanzada y de Conferencias Médicas y Telemedicina (CEDIMAT), Santo Domingo F3QG+PJ6, Dominican Republic.
- Departamento de Cardiología, Instituto Cardiovascular Sanatorio MIGONE, Asunción 1541, Paraguay.
- Departamento de Cardiología, Fundación Santa Fe, Bogota 110111, Colombia.
- Departamento de Cardiología, Instituto de Cardiología J. F. Cabral, Corrientes 3400, Argentina.
- Departamento de Cardiología, Hospital Luis Vernaza, Guayaquil 090306, Ecuador.
ORCID-Profile: Juan Pablo Arango-Ibanez, Miguel Angel Quintana Da Silva, Juan Esteban Gómez-Mesa
Förderung
- Tecnoquimicas S.A.
- Centro de Investigaciones Clínicas (CIC)
Zitieren
APA
Arango-Ibanez, J. P., Córdoba-Melo, B. D., Gutiérrez Posso, J. M., Barbosa-Rengifo, M. M., Herrera, C. J., Quintana Da Silva, M. A., Buitrago, A. F., Coronel Gilio, M. L., Pow-Chong-Long, F., & Gómez-Mesa, J. E. (2024). Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20–21 Registry. Viruses. https://doi.org/10.3390/v16071028
Vancouver
Arango-Ibanez JP, Córdoba-Melo BD, Gutiérrez Posso JM, Barbosa-Rengifo MM, Herrera CJ, Quintana Da Silva MA, et al. Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20–21 Registry. Viruses. 2024. doi:10.3390/v16071028
BibTeX
@article{ArangoIbanez2024,
author = {Arango-Ibanez, Juan Pablo and Córdoba-Melo, Brayan Daniel and Gutiérrez Posso, Juliana María and Barbosa-Rengifo, Mario Miguel and Herrera, Cesar J and Quintana Da Silva, Miguel Angel and Buitrago, Andrés Felipe and Coronel Gilio, María Lorena and Pow-Chong-Long, Freddy and Gómez-Mesa, Juan Esteban},
title = {Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20–21 Registry},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071028}
}
EUVIMED